中药防治颈动脉粥样硬化研究进展OA
Research Progress on Prevention and Treatment of Carotid Artery Atherosclerosis with Traditional Chinese Medicine
颈动脉粥样硬化(carotid atherosclerosis,CAS)核心病机属本虚标实,以虚、寒、痰、瘀、毒等因素互为因果,相互促进为特点.中药在CAS防治中具有多环节、多靶点、整体调节的独特优势.临床治疗CAS多从温阳化瘀、化痰泄浊、解毒通脉等角度辨证施治,在降低颈动脉内膜中层厚度、稳定斑块性质及改善血脂等方面均有良好临床疗效.中药复方或活性成分可通过抑制炎症、调控脂质代谢、自噬与细胞凋亡等机制延缓CAS的发生发展.未来研究可着重推进以下方向:构建CAS中医证候标准化体系,深化中药复方系统作用机制研究,推进活性成分向靶向药物转化,积累高质量临床循证证据,并建立中西医深度融合的协同干预模式.
The core pathogenesis of carotid atherosclerosis(CAS)is considered as deficiency in root with excess in symptom,character-ized by the interrelated and mutually reinforcing factors of deficiency,Cold,Phlegm,stasis,and Toxin.Traditional Chinese medicine(TCM)possesses unique advantages in multi-step,multi-target,and holistic regulation in the prevention and treatment of CAS.Clin-ical treatment of CAS is often guided by syndrome differentiation from the perspectives of warming Yang and promoting blood circula-tion,resolving Phlegm and eliminating Turbidity as well as detoxifying and unblocking the vessels.These approaches have shown good clinical efficacy in reducing carotid intima-media thickness,stabilizing plaque characteristics,and improving blood lipid profiles.TCM formulas or active components can delay the occurrence and progression of CAS through mechanisms such as inhibiting inflammation,regulating lipid metabolism,autophagy,and apoptosis.Future research could focus on the following directions:establishing a standard-ized TCM syndrome system for CAS,deepening the systematic research on the mechanisms of TCM formulas,promoting the transforma-tion of active components into targeted drugs,accumulating high-quality clinical evidence,and developing a synergistic intervention model of integrative medicine.
WANG Qingqing;WANG Zeqi;ZHANG Jin;LIU Wenjie;ZUO Wenxi;LI Cheng;YAO Kuiwu
Eye Hospital Affiliated to China Academy of Chinese Medical Sciences,Beijing China 100040Beijing University of Chinese Medicine,Beijing China 100029Beijing University of Chinese Medicine,Beijing China 100029Beijing University of Chinese Medicine,Beijing China 100029Guang'anmen Hospital Affiliated to China Academy of Chinese Medical Sciences,Beijing China 100053Eye Hospital Affiliated to China Academy of Chinese Medical Sciences,Beijing China 100040Guang'anmen Hospital Affiliated to China Academy of Chinese Medical Sciences,Beijing China 100053
医药卫生
颈动脉粥样硬化中医病机中药复方中药活性成分从阳虚论治从痰瘀论治从毒邪论治
carotid atherosclerosisTCM pathogenesisTCM compound formulaChinese medicineactive componenttreating from the perspective of Yang deficiencytreatment based on phlegm and blood stasistreating from the perspective of toxin
《中医学报》 2026 (1)
33-37,5
癌症、心脑血管、呼吸和代谢性疾病防治研究国家科技重大专项项目(四大慢病重大专项)(2024ZD0528300,2024ZD0528304)2024年岐黄学者培养项目(中医药领军人才培养项目){国中医药人教函[2025]182号}北京中医药薪火传承"新3+3"工程室站建设项目(2023-SZ-H-13)
评论